Eupraxia Pharmaceuticals Inc EPRX

TOR: EPRX | ISIN: CA29842P1053 16/07/2025

7,430 CAD (+1,36%)

(+1,36%) 16/07/2025

Grafiek Eupraxia Pharmaceuticals Inc

Grafiek Eupraxia Pharmaceuticals Inc

1 dag1d 1,36%
1 week1w -2,62%
1 maand1m 25,51%
3 maanden3m 62,94%
6 maanden6m 60,48%
1 jaar1j 115,36%
5 jaar5j 7,68%

Eupraxia Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

20 maart 2025 · Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results · Persbericht

11 september 2024 · Eupraxia Pharmaceuticals Announces Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis · Persbericht

11 september 2024 · Eupraxia Pharmaceuticals Announces Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis · Persbericht

4 september 2024 · Eupraxia Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference · Persbericht

4 september 2024 · Eupraxia Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference · Persbericht

7 augustus 2024 · Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results · Persbericht

2 augustus 2024 · Eupraxia Pharmaceuticals Announces New C$12 Million Convertible Debt Facility · Persbericht

2 augustus 2024 · Eupraxia Pharmaceuticals Announces New C$12 Million Convertible Debt Facility · Persbericht

8 juli 2024 · Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo · Persbericht

8 juli 2024 · Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe